ACOR
Acorda Therapeutics
ACOR
ACOR
Delisted
ACOR was delisted on the 11th of April, 2024.
175 hedge funds and large institutions have $899M invested in Acorda Therapeutics in 2016 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 59 increasing their positions, 57 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
11% less capital invested
Capital invested by funds: $1.01B → $899M (-$108M)
83% less call options, than puts
Call options by funds: $7.01M | Put options by funds: $40.8M
Holders
175
Holding in Top 10
1
Calls
$7.01M
Puts
$40.8M
Top Buyers
| 1 | +$13.5M | |
| 2 | +$11.8M | |
| 3 | +$6.17M | |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
+$4.96M |
| 5 |
Millennium Management
New York
|
+$4.58M |
Top Sellers
| 1 | -$13M | |
| 2 | -$10.3M | |
| 3 | -$8.01M | |
| 4 |
Westfield Capital Management
Boston,
Massachusetts
|
-$7.43M |
| 5 |
Goldman Sachs
New York
|
-$7.15M |